Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating restated by research analysts at FinnCap in a research report issued on Tuesday. They currently have a GBX 100 ($1.31) price objective on the stock. FinnCap’s target price indicates a potential upside of 30.72% from the company’s previous close.

Shares of Cambridge Cognition Holdings PLC (LON:COG) opened at 72.00 on Tuesday. The firm’s 50-day moving average price is GBX 55.88 and its 200-day moving average price is GBX 44.98. The firm’s market cap is GBX 12.18 million. Cambridge Cognition Holdings PLC has a 52 week low of GBX 30.00 and a 52 week high of GBX 105.00.

About Cambridge Cognition Holdings PLC

Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with's FREE daily email newsletter.